Trials / Recruiting
RecruitingNCT05742178
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation Randomized Controlled Trial (NYC CONNECT)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,160 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" \[PN\] arm) versus providing culturally and linguistically tailored cancer education only (the "less intensive" \[LI\] arm). The study population will include individuals who are due for breast, cervical, or colorectal cancer screening. All individuals recruited to the study will be provided navigation for unmet social determinants of health (SDH) needs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Patient Navigation (PN) - More Intensive | The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for cancer screening status and social needs and provide navigational support to cancer screening and social services. |
| BEHAVIORAL | Educational Materials | Both PN and LI participants will receive tailored educational materials around cancer screening and SDH resources as needed. |
| BEHAVIORAL | Patient Navigation (PN) - Less Intensive | The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for social needs and provide navigational support to social services. |
Timeline
- Start date
- 2023-07-05
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2023-02-23
- Last updated
- 2025-12-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05742178. Inclusion in this directory is not an endorsement.